The following is a listing of recent U.S. Food and Drug Administration activities and updates:

• Regulatory Considerations for Prescription Drug Use-Related Software

• FDA Issues Final Guidance on Cybersecurity in Medical Devices

• Sucralfate Oral Suspension, 1g/10mL by VistaPharm: Recall - Due to Microbial Contamination Identified as Bacillus cereus

• Universal Meditech Inc. Expands Nationwide Recall to All Products Manufactured between March 2021 and November 2022

…

Sign Up for Free Trial

---

• Back
• MCN Blog